Risks of anti-inflammatory drug-associated damage

Inflammation Research

Volumn 48, Issue 5, 1999, Pages 236-238

  Langman, M J S ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

GASTROINTESTINAL TOXICITY; NOTE; PEPTIC ULCER;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GASTROINTESTINAL DISEASES; HUMANS; RISK ASSESSMENT; STOMACH ULCER;

EID: 0033030327     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050453     Document Type: Note

References (3)

1. [1] Langman MJS, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RFA, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-8.
2. [2] Weil J, Colin Jones DG, Langman M, Lawson D, Logan R, Murphy M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. Brit Med J 1995; 310:827-30.
3. [3] Henry D, Lim LL-Y, Garcia Rodriguez LA, Perez Gutthann S, Carson JL, Griffin M, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. Brit Med J 1996; 312: 1563-6.